Francisco Javier Rupérez
Senior research scientist
Francisco Javier Rupérez
Web of Science ResearcherID: https://www.webofscience.com/wos/author/record/1548497
Bio: Francisco Javier Rupérez Pascualena is a Biochemist and currently Lecturer in Bioanalysis and related subjects at Universidad CEU San Pablo, Madrid (Spain). He holds a PhD in Pharmacy from Universidad CEU San Pablo and his research career continued as co-founder and active member of CEMBIO (Madrid, Spain). His experience as researcher and teacher has been developed over the past 23 years, counting with more than 60 publications in journals included in JCR. He has directed Master projects and PhD theses. He actively participates in competitive research projects and in different cooperation contracts with public entities and private companies. He is interested in all stages of the Metabolomics workflow, but specially focused in the methodology for LC/MS, as well as the biochemical interpretation. On top of all, he is strongly involved in the collaborative research characteristic of Metabolomics, because “Eowawa! THUS do we do in the CEMBIO!”.
Web of Science ResearcherID: I-8360-2012
ORCID: 0000-0001-6457-6234
Publications by Francisco Javier Rupérez:
Identifying subgroups of childhood obesity by using multiplatform metabotyping
Posted on: 20 Dic 2023
Inks in the Analytical Laboratory: A Forensics Activity for Undergraduate Students
Posted on: 18 Ago 2023
Impact of renal tubular Cpt1a overexpression on the kidney metabolome in the folic acid-induced fibrosis mouse model
Posted on: 12 Jun 2023
γ-Linolenic acid in maternal milk drives cardiac metabolic maturation
Posted on: 24 May 2023
Editorial: Advances and challenges in untargeted metabolomics
Posted on: 10 Feb 2023
Untargeted Metabolomics Studies of H9c2 Cardiac Cells Submitted to Oxidative Stress, β-Adrenergic Stimulation and Doxorubicin Treatment: Investigation of Cardiac Biomarkers
Posted on: 29 Jun 2022
Lipidomic and Metabolomic Signature of Progression of Chronic Kidney Disease in Patients with Severe Obesity
Posted on: 03 Dic 2021
Unveiling Metabolic Phenotype Alterations in Anorexia Nervosa through Metabolomics
Posted on: 26 Nov 2021
Transforming growth factor β3 deficiency promotes defective lipid metabolism and fibrosis in murine kidney
Posted on: 01 Oct 2021
Insulin Resistance in Obese Children: What Can Metabolomics and Adipokine Modelling Contribute?
Posted on: 29 Oct 2020
Dysregulation of glycerophospholipid metabolism during Behçet’s disease contributes to a pro-inflammatory phenotype of circulating monocytes
Posted on: 11 May 2020
Plasma Metabolic Signature of Atherosclerosis Progression and Colchicine Treatment in Rabbits
Posted on: 27 Abr 2020
Impact of global PTP1B deficiency on the gut barrier permeability during NASH in mice
Posted on: 06 Feb 2020
Metabolic impact of partial hepatectomy in the non-alcoholic steatohepatitis animal model of methionine-choline deficient diet
Posted on: 01 Nov 2019
Recent Developments along the Analytical Process for Metabolomics Workflows
Posted on: 18 Oct 2019
LAS: A Lipid Annotation Service Capable of Explaining the Annotations It Generates
Posted on: 30 Jul 2019
Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury
Posted on: 16 Jul 2019
Microbiota Sensing by Mincle-Syk Axis in Dendritic Cells Regulates Interleukin-17 and -22 Production and Promotes Intestinal Barrier Integrity
Posted on: 19 Feb 2019
Differential Effects of a Glucagon-Like Peptide 1 Receptor Agonist in Non-Alcoholic Fatty Liver Disease and in Response to Hepatectomy
Posted on: 07 Nov 2018
Flow Cytometry Has a Significant Impact on the Cellular Metabolome
Posted on: 26 Oct 2018
Metabolomics changes in patients with PAPP-A2 deficiency in response to rhIGF1 treatment
Posted on: 12 Ago 2018
Metabolómica
Posted on: 09 Jul 2018
Knowledge-based metabolite annotation tool: CEU Mass Mediator
Posted on: 30 May 2018
Stereochemical and structural effects of (2R,6R)-hydroxynorketamine on the mitochondrial metabolome in PC-12 cells
Posted on: 09 Mar 2018
Multiplatform plasma fingerprinting in cancer cachexia: a pilot observational and translational study
Posted on: 20 Feb 2018
Discriminant biomarkers of acute respiratory distress syndrome associated to H1N1 influenza identified by metabolomics HPLC-QTOF-MS/MS platform
Posted on: 17 Jul 2017
Metabolomics allows the discrimination of the pathophysiological relevance of hyperinsulinism in obese prepubertal children
Posted on: 07 Jun 2017
A metabolomic approach shows sphingosine 1-phosphate and lysophospholipids as mediators of the therapeutic effect of liver growth factor in emphysema
Posted on: 30 May 2017
A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice
Posted on: 23 Nov 2016